Oragenics inc (OGEN)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Net loss

-15,566

-9,914

-6,731

-7,013

-11,711

-5,789

-16,068

-13,090

-7,678

-7,805

Adjustments to reconcile net loss to net cash used in operating activities:
Technology access fee paid in convertible note payable to shareholder

-

-

-

-

5,000

-

-

-

-

-

Technology access fee paid in common stock and convertible note payable to shareholder

-

-

-

-

-

-

6,000

-

-

-

Stock retention awards

-

-

-

-

-

-

-

-

140

-

Accretion of discount on notes payable to shareholder

-

-

-

-

-

-

-

483

-

-

Depreciation and amortization

62

30

65

75

71

27

76

75

79

-

Stock issued as compensation to non-employee directors

-

24

-

-

-

-

-

-

-

-

Warrant issued in exchange for services

-

-

118

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

42

Stock-based compensation expense

552

996

-

-

-

184

-

1,280

1,262

667

Loss on sale of fixed assets

-

-

-

-3

1

-0

-

-

-

-

Stock issued as compensation to non-employee directors

-

-

123

151

264

-

-

-

-

-

Stock-based compensation expense

-

-

437

487

770

-

3,449

-

-

-

Stock issued in exchange for services

12

12

-

-

-

102

-

5,798

-

99

Gain on sale of discontinued operations

-

-

-

1,453

-

-

-

-

-

-

Decrease in fair value of derivative liability

-

-

188

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

-

-

-

-

-

-48

-5

-22

-30

-39

Income tax receivable

-

-

-

-

-

-

-

-

-362

362

Inventory, net

-

-

-

-

-

150

164

-351

208

134

Prepaid expenses and other current assets

-1,427

453

713

-229

-68

-214

-203

-26

-153

-4

Accounts payable and accrued expenses

498

225

525

446

348

-199

-234

-57

225

1,036

Net cash used in operating activities

-13,012

-9,079

-6,363

-7,075

-5,189

-

-

-

-5,494

-6,448

Cash flows from investing activities:
Proceeds from sale of fixed assets

-

-

-

2

1

0

-

-

-

-

Deferred revenue

-

-

-

-

-

2

-32

-101

139

-36

Net cash used in operating activities

-

-

-

-

-

-5,559

-6,764

-5,211

-

-

Purchase of property and equipment

25

124

-

27

102

110

18

11

-

88

Proceeds from payment of note receivable

-

-

-

250

-

-

-

-

-

-

Proceeds from sale of discontinued operations

-

-

-

1,450

-

-

-

-

-

-

Proceeds from payment of note receivable

-

-

-

-

-

-

-

750

-

-

Net cash used by investing activities

-25

-124

-

1,675

-101

-

-

-

-

-88

Cash flows from financing activities:
Exercise of common stock options

-

-

-

-

-

-

39

-

-

-

Borrowings under note payable to shareholder

-

-

-

-

-

-

-

-

-

1,000

Borrowings under convertible secured note payable to shareholder

-

-

-

-

-

-

-

2,500

5,500

2,000

Payments on short-term notes payable

252

200

-

-

-

-

140

140

-

-

Net cash used in investing activities

-

-

-

-

-

-110

-18

-11

-

-

Payments on short-term notes payable

-

-

-157

-158

-159

-158

-

-

-

-

Proceeds from issuance of note payable to shareholder

-

-

2,400

-

-

-

-

-

-

-

Net proceeds from issuance of common stock, convertible preferred stock, and warrants

11,350

12,431

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock for warrant exercise

-

9,505

-

-

-

-

-

-

-

-

Net proceeds from issuance of convertible preferred stock and warrants

-

-

6,176

-

-

-

-

-

-

-

Proceeds from payment of stock subscription receivable

-

-

30

1,969

-

-

-

-

-

-

Net proceeds from issuance of common stock and warrants

-

1,510

-

-

-

-

-

-

-

-

Payment of income taxes associated with stock based compensation

-

-

-

-

-

-

631

224

-

-

Payments on short term notes payable

-

-

-

-

-

-

-

-

172

107

Net proceeds from issuance of common stock

-

-

-

2,640

-

-

13,804

11,888

-

1,500

Purchase of treasury stock

-

-

-

-

-

-

-

-

3

-

Restricted cash (receipts) released, net

-

-

-

-

-

-

61

203

210

1,974

Net cash provided by (used in) financing activities

11,097

23,246

8,449

4,451

-159

-

-

-

5,534

6,367

Net increase (decrease) in cash and cash equivalents

-1,940

14,042

-

-

-

-

-

-

-

-

Net cash used in financing activities

-

-

-

-

-

-158

13,133

14,977

-

-

Net increase in cash and cash equivalents

-

-

2,085

-948

-5,450

-5,827

6,350

9,754

39

-169

Operating cash flows from discontinued operations

-

-

-

-54

85

-

-

-

-

-

Supplemental disclosure of cash flow information:
Par value of common stock issued for cashless exercise of warrants

-

-

-

-

0

0

0

0

-

-

Par value of restricted shares forfeited

-

-

-

0

-

-

-

-

-

-

Interest paid

7

5

4

-

-

-

-

-

-

21

Interest paid

-

-

-

4

5

4

3

3

5

-

Non-cash investing and financing activities:
Conversion of convertible note payable and accrued interest to common shares

-

-

-

-

5,071

-

1,969

-

-

-

Borrowings under short term notes payable for prepaid expense

272

244

172

161

158

-

-

-

-

-

Par value of restricted shares issued

-

0

-

-

-

-

-

-

-

-

Stock dividend on Series C preferred stock

413

58

-

-

-

-

-

-

-

-

Short-term note receivable from stockholder in exchange for the issuance of common stock

-

-

-

2,000

-

-

-

-

-

-

Borrowings under short term notes payable for prepaid expense

-

-

-

-

-

158

157

134

126

-

Par value of restricted shares issued

-

-

0

0

0

-

-

-

-

-

Deemed dividend on Series D preferred stock

-

1,412

-

-

-

-

-

-

-

-

Par value of common stock issued in exchange for services

0

0

-

-

-

-

-

-

-

-

Fair market value of 48,387 warrants issued for financial advisory services

-

-

118

-

-

-

-

-

-

-

Borrowings under short term notes payable for prepaid expense

-

-

-

-

-

-

-

-

-

63

Par value of restricted stock granted as stock compensation

-

-

-

-

-

-

-

-

0

-

Debt converted to Series C preferred stock

-

-

-

-

-

-

-

11,275

-

-

Discount on note payable to shareholder for warrants issued

-

-

-

-

-

-

-

483

-

-

Par value of forfeited stock

-

-

-

-

-

-

-

5.00

-

-

Fair market value of the 771,169 warrants issued to Placement Agent as a reduction in paid in capital from issuance of common stock

-

-

-

-

-

-

-

1,939

-

-

Common stock issued in exchange for cancellation of note payable to shareholder

-

-

-

-

-

-

-

-

-

1,000

Borrowings under short term notes payable for purchase of property and equipment

-

-

-

-

-

-

-

-

-

107

Series A Preferred Stock [Member]
Par value of common stock issued in connection with stock conversion

-

0

-

-

-

-

-

-

-

-

Conversion of preferred stock into common stock

-

268

-

-

-

-

-

-

-

-

Series D Preferred Stock [Member]
Par value of common stock issued in connection with stock conversion

-

9

-

-

-

-

-

-

-

-

Conversion of preferred stock into common stock

-

4,464

-

-

-

-

-

-

-

-